Amedisys Pays $44M To End Investors' Medicare Fraud Suit
Amedisys Inc. has agreed to pay $43.75 million to settle a shareholder suit alleging the health care provider and its top executives hid a Medicare fraud scheme that caused its stock...To view the full article, register now.
Already a subscriber? Click here to view full article